Long-term Follow-up of Subjects Exposed to Lentiviral-based CART-EGFRvIII Gene-modified Cellular Therapy Products in Cancer Studies

Clinical trial NCT02666248 · COMPLETED

Trial details

NCT number: NCT02666248
Sponsor: University of Pennsylvania
Status: COMPLETED
Study type: OBSERVATIONAL

Subjects Entering Into This Protocol Will be Followed for up to 15 Years After Initial CART-EGFRvIII Infusion

Start date: 2016-05-23
Primary completion: 2018-01-27
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.